NPM1 Mutation
9 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid Leukemia (NCT04867928) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2022-03-01 |
Track NPM1 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.